Absolute quantification of choline-related biomarkers in breast cancer biopsies by liquid chromatography electrospray ionization mass spectrometry

Maria Chiara Mimmi, Nicoletta Finato, Gloria Pizzolato, Carlo Alberto Beltrami, Federico Fogolari, Alessandra Corazza, Gennaro Esposito

    Research output: Contribution to journalArticle

    Abstract

    It has been repeatedly demonstrated that choline metabolism is altered in a wide variety of cancers. In breast tumours, the choline metabolite profile is characterized by an elevation of phosphocholine and total choline-compounds. This pattern is increasingly being exploited as biomarker in cancer diagnosis. The majority of in vitro metabolomics studies, for biomarkers quantification in cell cultures or tissues, entail proton NMR spectroscopy. Although many 'targeted' approaches have been proposed to quantify metabolites from standard one-dimensional (1D) NMR experiments, the task is often made difficult by the high degree of overlap characterizing 1H NMR spectra of biological samples. Here we present an optimized protocol for tissue extraction and absolute quantification of choline, phosphocholine and glycerophosphocholine by means of liquid chromatography electrospray ionization mass spectrometry (LC-ESI-MS). The selected chromatographic separation system with a HILIC (hydrophilic interaction chromatography) amide column effectively separates free choline and its phopshorylated derivatives, contrary to failure observed using standard reversed-phase chromatography. The metabolite absolute quantification is based on external calibration with commercial standards, and is validated by a parallel 1D proton NMR analysis. The LC-MS/NMR analysis is applied to three breast carcinoma specimens obtained by surgical excision, each one accompanied by a control tissue sample taken outside the tumor margin. The metabolite concentrations measured are in good agreement with previous results on metabolic profile changes of breast cancer. Each of the three cancerous biopsies, when compared with the control tissue, exhibit a highly increased levels phosphocholine, total choline and phosphocholine/glycerophosphocholine ratio.

    Original languageEnglish (US)
    Pages (from-to)71-83
    Number of pages13
    JournalAnalytical Cellular Pathology
    Volume36
    Issue number3-4
    DOIs
    StatePublished - Nov 25 2013

    Fingerprint

    Electrospray Ionization Mass Spectrometry
    Choline
    Liquid Chromatography
    Phosphorylcholine
    Biomarkers
    Breast Neoplasms
    Biopsy
    Protons
    Metabolomics
    Metabolome
    Reverse-Phase Chromatography
    Tumor Biomarkers
    Hydrophobic and Hydrophilic Interactions
    Amides
    Calibration
    Chromatography
    Neoplasms
    Magnetic Resonance Spectroscopy
    Cell Culture Techniques

    Keywords

    • $^1$H-NMR
    • breast cancer
    • choline phospholipid metabolism
    • hydrophilic interaction chromatography
    • LC-ESI-MS
    • Metabolomics

    ASJC Scopus subject areas

    • Cancer Research
    • Molecular Medicine
    • Pathology and Forensic Medicine
    • Cell Biology

    Cite this

    Absolute quantification of choline-related biomarkers in breast cancer biopsies by liquid chromatography electrospray ionization mass spectrometry. / Mimmi, Maria Chiara; Finato, Nicoletta; Pizzolato, Gloria; Beltrami, Carlo Alberto; Fogolari, Federico; Corazza, Alessandra; Esposito, Gennaro.

    In: Analytical Cellular Pathology, Vol. 36, No. 3-4, 25.11.2013, p. 71-83.

    Research output: Contribution to journalArticle

    Mimmi, Maria Chiara ; Finato, Nicoletta ; Pizzolato, Gloria ; Beltrami, Carlo Alberto ; Fogolari, Federico ; Corazza, Alessandra ; Esposito, Gennaro. / Absolute quantification of choline-related biomarkers in breast cancer biopsies by liquid chromatography electrospray ionization mass spectrometry. In: Analytical Cellular Pathology. 2013 ; Vol. 36, No. 3-4. pp. 71-83.
    @article{e3be182bb8f141d9b12055856401c10b,
    title = "Absolute quantification of choline-related biomarkers in breast cancer biopsies by liquid chromatography electrospray ionization mass spectrometry",
    abstract = "It has been repeatedly demonstrated that choline metabolism is altered in a wide variety of cancers. In breast tumours, the choline metabolite profile is characterized by an elevation of phosphocholine and total choline-compounds. This pattern is increasingly being exploited as biomarker in cancer diagnosis. The majority of in vitro metabolomics studies, for biomarkers quantification in cell cultures or tissues, entail proton NMR spectroscopy. Although many 'targeted' approaches have been proposed to quantify metabolites from standard one-dimensional (1D) NMR experiments, the task is often made difficult by the high degree of overlap characterizing 1H NMR spectra of biological samples. Here we present an optimized protocol for tissue extraction and absolute quantification of choline, phosphocholine and glycerophosphocholine by means of liquid chromatography electrospray ionization mass spectrometry (LC-ESI-MS). The selected chromatographic separation system with a HILIC (hydrophilic interaction chromatography) amide column effectively separates free choline and its phopshorylated derivatives, contrary to failure observed using standard reversed-phase chromatography. The metabolite absolute quantification is based on external calibration with commercial standards, and is validated by a parallel 1D proton NMR analysis. The LC-MS/NMR analysis is applied to three breast carcinoma specimens obtained by surgical excision, each one accompanied by a control tissue sample taken outside the tumor margin. The metabolite concentrations measured are in good agreement with previous results on metabolic profile changes of breast cancer. Each of the three cancerous biopsies, when compared with the control tissue, exhibit a highly increased levels phosphocholine, total choline and phosphocholine/glycerophosphocholine ratio.",
    keywords = "$^1$H-NMR, breast cancer, choline phospholipid metabolism, hydrophilic interaction chromatography, LC-ESI-MS, Metabolomics",
    author = "Mimmi, {Maria Chiara} and Nicoletta Finato and Gloria Pizzolato and Beltrami, {Carlo Alberto} and Federico Fogolari and Alessandra Corazza and Gennaro Esposito",
    year = "2013",
    month = "11",
    day = "25",
    doi = "10.3233/ACP-130082",
    language = "English (US)",
    volume = "36",
    pages = "71--83",
    journal = "Analytical Cellular Pathology",
    issn = "2210-7177",
    publisher = "IOS Press",
    number = "3-4",

    }

    TY - JOUR

    T1 - Absolute quantification of choline-related biomarkers in breast cancer biopsies by liquid chromatography electrospray ionization mass spectrometry

    AU - Mimmi, Maria Chiara

    AU - Finato, Nicoletta

    AU - Pizzolato, Gloria

    AU - Beltrami, Carlo Alberto

    AU - Fogolari, Federico

    AU - Corazza, Alessandra

    AU - Esposito, Gennaro

    PY - 2013/11/25

    Y1 - 2013/11/25

    N2 - It has been repeatedly demonstrated that choline metabolism is altered in a wide variety of cancers. In breast tumours, the choline metabolite profile is characterized by an elevation of phosphocholine and total choline-compounds. This pattern is increasingly being exploited as biomarker in cancer diagnosis. The majority of in vitro metabolomics studies, for biomarkers quantification in cell cultures or tissues, entail proton NMR spectroscopy. Although many 'targeted' approaches have been proposed to quantify metabolites from standard one-dimensional (1D) NMR experiments, the task is often made difficult by the high degree of overlap characterizing 1H NMR spectra of biological samples. Here we present an optimized protocol for tissue extraction and absolute quantification of choline, phosphocholine and glycerophosphocholine by means of liquid chromatography electrospray ionization mass spectrometry (LC-ESI-MS). The selected chromatographic separation system with a HILIC (hydrophilic interaction chromatography) amide column effectively separates free choline and its phopshorylated derivatives, contrary to failure observed using standard reversed-phase chromatography. The metabolite absolute quantification is based on external calibration with commercial standards, and is validated by a parallel 1D proton NMR analysis. The LC-MS/NMR analysis is applied to three breast carcinoma specimens obtained by surgical excision, each one accompanied by a control tissue sample taken outside the tumor margin. The metabolite concentrations measured are in good agreement with previous results on metabolic profile changes of breast cancer. Each of the three cancerous biopsies, when compared with the control tissue, exhibit a highly increased levels phosphocholine, total choline and phosphocholine/glycerophosphocholine ratio.

    AB - It has been repeatedly demonstrated that choline metabolism is altered in a wide variety of cancers. In breast tumours, the choline metabolite profile is characterized by an elevation of phosphocholine and total choline-compounds. This pattern is increasingly being exploited as biomarker in cancer diagnosis. The majority of in vitro metabolomics studies, for biomarkers quantification in cell cultures or tissues, entail proton NMR spectroscopy. Although many 'targeted' approaches have been proposed to quantify metabolites from standard one-dimensional (1D) NMR experiments, the task is often made difficult by the high degree of overlap characterizing 1H NMR spectra of biological samples. Here we present an optimized protocol for tissue extraction and absolute quantification of choline, phosphocholine and glycerophosphocholine by means of liquid chromatography electrospray ionization mass spectrometry (LC-ESI-MS). The selected chromatographic separation system with a HILIC (hydrophilic interaction chromatography) amide column effectively separates free choline and its phopshorylated derivatives, contrary to failure observed using standard reversed-phase chromatography. The metabolite absolute quantification is based on external calibration with commercial standards, and is validated by a parallel 1D proton NMR analysis. The LC-MS/NMR analysis is applied to three breast carcinoma specimens obtained by surgical excision, each one accompanied by a control tissue sample taken outside the tumor margin. The metabolite concentrations measured are in good agreement with previous results on metabolic profile changes of breast cancer. Each of the three cancerous biopsies, when compared with the control tissue, exhibit a highly increased levels phosphocholine, total choline and phosphocholine/glycerophosphocholine ratio.

    KW - $^1$H-NMR

    KW - breast cancer

    KW - choline phospholipid metabolism

    KW - hydrophilic interaction chromatography

    KW - LC-ESI-MS

    KW - Metabolomics

    UR - http://www.scopus.com/inward/record.url?scp=84887889506&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84887889506&partnerID=8YFLogxK

    U2 - 10.3233/ACP-130082

    DO - 10.3233/ACP-130082

    M3 - Article

    VL - 36

    SP - 71

    EP - 83

    JO - Analytical Cellular Pathology

    JF - Analytical Cellular Pathology

    SN - 2210-7177

    IS - 3-4

    ER -